ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,482Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 917

$469K Total Retail Price of All Prescriptions

Rank: 135 out of 917

599 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,369 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 339 322 1 1
LEVOTHYROXINE SODIUM 243 218 2 3
PRAVASTATIN SODIUM 231 201 3 20
OXYCODONE HCL 213 85 S2 4 27
METFORMIN HCL 204 189 5 8
HYDROCODONE-ACETAMINOPHEN 195 162 S3 6 6
ZOLPIDEM TARTRATE 191 138 7 21
LOVASTATIN 174 165 8 19
AMLODIPINE BESYLATE 166 162 9 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 131 10 42
WARFARIN SODIUM 139 137 11 10
METOPROLOL SUCCINATE 131 111 12 18
FUROSEMIDE 129 117 13 7
SIMVASTATIN 129 109 13 2
OMEPRAZOLE 122 115 15 4
ALLOPURINOL 112 106 16 31
LOSARTAN POTASSIUM 104 99 17 13
HYDROCHLOROTHIAZIDE 84 81 18 9
LOSARTAN-HYDROCHLOROTHIAZIDE 83 77 19 62
TRAMADOL HCL 83 63 19 28
POTASSIUM CHLORIDE 81 80 21 16
GABAPENTIN 78 57 22 17
MORPHINE SULFATE ER 76 43 S2 23 48
ATENOLOL 74 65 24 12
METOPROLOL TARTRATE 72 61 25 11
TAMSULOSIN HCL 71 59 26 25
FINASTERIDE 69 69 27 77
ATORVASTATIN CALCIUM 68 63 28 14
CARBIDOPA-LEVODOPA 67 65 29 86
CARVEDILOL 65 60 30 33
SERTRALINE HCL 63 62 31 24
GLIMEPIRIDE 61 60 32 54
CITALOPRAM HBR 61 51 32 15
PAROXETINE HCL 61 61 32 57
NADOLOL 56 56 35 302
TRAZODONE HCL 54 34 36 22
ALENDRONATE SODIUM 52 37 37 23
OXYCONTIN 52 15 S2 37 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.